A leader of these investigations was the physician-scientist Eloise Giblett (6), whose interest in purine metabolism began when she identified a complete lack of blood ADA activity in a patient with severe combined immunodeficiency (SCID). The gene discussed is ADA; the disease is immune system disorder.